Pay in 4 interest-free payments of $5.17 Learn more
Ships within 48 hours · Estimated delivery Aug 6 - Aug 11
Targets both GLP-1 and GIP receptors Greater average weight loss than Semaglutide in clinical trials Reduces appetite and improves metabolic function Weekly self-injection FDA-approved for chronic weight management Tirzepatide at Bloom Aesthetics + Wellness $749 for a 10-week program
Ghrelin Receptor Inverse Agonist for Clinical Study The short-term use of ghrelin receptor antagonists has shown promising effects for weight control, but their long-term efficacy remains limited
GLP-1 Cycling: At $200/mo (via employers) or DTC, cycling dynamics will increase
Ondansetron is a selective 5-HT (serotonin type 3) receptor antagonist
Treatment can also be continued until target weight is achieved
W., Tedjasaputra, V., Bailey, D
